Efficient and Scalable T Cell Engineering for Advancing Cancer Immunotherapy of Hepatocellular Carcinoma by a cGmp-Compliant Non-Viral Cell Engineering Platform

2022-06-24T22:14:33+00:00June 24th, 2022|Comments Off on Efficient and Scalable T Cell Engineering for Advancing Cancer Immunotherapy of Hepatocellular Carcinoma by a cGmp-Compliant Non-Viral Cell Engineering Platform

Hybrid ssDNA repair templates enable high yield genome engineering in primary cells for disease modeling and cell therapy manufacturing

2022-04-22T18:40:17+00:00April 22nd, 2022|Comments Off on Hybrid ssDNA repair templates enable high yield genome engineering in primary cells for disease modeling and cell therapy manufacturing

Electroporation of a Non-Integrative DNA Nanovector for Efficient, Semi-Automated, GMP Manufacturing of CAR T Cell Therapies

2022-03-19T14:44:04+00:00March 2nd, 2022|Comments Off on Electroporation of a Non-Integrative DNA Nanovector for Efficient, Semi-Automated, GMP Manufacturing of CAR T Cell Therapies

MaxCyte Flow Electroporation® Technology: A Safe, Reliable and Effective Method for Engineering CAR T Cells

2022-07-14T14:47:35+00:00December 6th, 2021|Comments Off on MaxCyte Flow Electroporation® Technology: A Safe, Reliable and Effective Method for Engineering CAR T Cells

Electroporation of a Non-Integrative DNA Nanovector for Efficient, Semi-Automated, GMP Manufacturing of CAR T Cell Therapies

2021-12-06T23:55:06+00:00December 6th, 2021|Comments Off on Electroporation of a Non-Integrative DNA Nanovector for Efficient, Semi-Automated, GMP Manufacturing of CAR T Cell Therapies
Go to Top